Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe James

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Translational Medicine|March 8, 2024
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 diseaseGeoffrey Garcia, Sylvie Labrouche-Colomer, Alexandre Duvignaud, et al.
Elife|December 12, 2024
Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studiesSami Fawaz, Severine Marti, Melody Dufossee, et al.
Blood|July 10, 2008
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneityChloe James, Frederic Mazurier, Sabrina Dupont, et al.
Haematologica|September 2, 2018
Vascular endothelial cell expression of JAK2<sup>V617F</sup> is sufficient to promote a pro-thrombotic state due to increased P-selectin expressionAlexandre Guy, Virginie Gourdou-Latyszenok, Nicolas Le Lay, et al.
Haematologica|February 8, 2024
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifsJean Galtier, Louis Drevon, Yannick Le Bris, et al.
Blood|July 5, 2011
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemiaDominique Bluteau, Laure Gilles, Morgane Hilpert, et al.
FEMS Microbiology Ecology|April 6, 2017
Fifty important research questions in microbial ecologyRachael E Antwis, Sarah M Griffiths, Xavier A Harrison, et al.
Leukemia|December 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasmsAlexandre Guy, Olivier Mansier, Matisse Decilap, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Leukemia|March 13, 2025
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia veraYan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Translational Medicine|March 8, 2024
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 diseaseGeoffrey Garcia, Sylvie Labrouche-Colomer, Alexandre Duvignaud, et al.
Elife|December 12, 2024
Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studiesSami Fawaz, Severine Marti, Melody Dufossee, et al.
Blood|July 10, 2008
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneityChloe James, Frederic Mazurier, Sabrina Dupont, et al.
Haematologica|September 2, 2018
Vascular endothelial cell expression of JAK2<sup>V617F</sup> is sufficient to promote a pro-thrombotic state due to increased P-selectin expressionAlexandre Guy, Virginie Gourdou-Latyszenok, Nicolas Le Lay, et al.
Haematologica|February 8, 2024
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifsJean Galtier, Louis Drevon, Yannick Le Bris, et al.
Blood|July 5, 2011
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemiaDominique Bluteau, Laure Gilles, Morgane Hilpert, et al.
FEMS Microbiology Ecology|April 6, 2017
Fifty important research questions in microbial ecologyRachael E Antwis, Sarah M Griffiths, Xavier A Harrison, et al.
Leukemia|December 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasmsAlexandre Guy, Olivier Mansier, Matisse Decilap, et al.
Annals of Hematology|March 4, 2024
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment optionsJean-Jacques Kiladjian, Francisca Ferrer Marin, Haifa Kathrin Al-Ali, et al.
Leukemia|March 13, 2025
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia veraYan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, et al.
Pageof 2